Cytochalasin E
![]() | |
| Identifiers | |
|---|---|
| 36011-19-5 | |
| ChemSpider | 4572350 |
| EC Number | 252-835-7 |
| Jmol interactive 3D | Image |
| PubChem | 5458385 |
| |
| |
| Properties | |
| C28H33NO7 | |
| Molar mass | 495.57 g·mol−1 |
| Density | 1.309 g/ml |
| Hazards | |
| Main hazards | Toxic |
| EU classification (DSD) |
T+ |
| R-phrases | R26/27/28 R63 |
| S-phrases | S28 S36/37 S45 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Cytochalasin E, a member of the cytochalasin group, is an inhibitor of actin polymerization in blood platelets. It inhibits angiogenesis and tumor growth. Unlike cytochalasin A and cytochalasin B, it does not inhibit glucose transport.
Because of its antiangiogenic effect, cytochalasin E is a potential drug for age-related macular degeneration, a kind of blindness caused by an abnormal proliferation of blood vessels in the eye.[2]
References
External pages
Cytochalasin E from Fermentek
Cytochalasin E from Cayman Chemical
This article is issued from Wikipedia - version of the Monday, November 16, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
